[go: up one dir, main page]

AU5204800A - Process for preparing sildenafil, and troche which comprises sildenafil and apomorphine - Google Patents

Process for preparing sildenafil, and troche which comprises sildenafil and apomorphine

Info

Publication number
AU5204800A
AU5204800A AU52048/00A AU5204800A AU5204800A AU 5204800 A AU5204800 A AU 5204800A AU 52048/00 A AU52048/00 A AU 52048/00A AU 5204800 A AU5204800 A AU 5204800A AU 5204800 A AU5204800 A AU 5204800A
Authority
AU
Australia
Prior art keywords
sildenafil
troche
apomorphine
preparing
comprises sildenafil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52048/00A
Inventor
Ding Sheng Ding
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biochemical Pharmaceutical Factory Of Zhuhai Sez
Original Assignee
BIOCHEMICAL PHARMACEUTICAL FAC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOCHEMICAL PHARMACEUTICAL FAC filed Critical BIOCHEMICAL PHARMACEUTICAL FAC
Publication of AU5204800A publication Critical patent/AU5204800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU52048/00A 1999-06-21 2000-06-08 Process for preparing sildenafil, and troche which comprises sildenafil and apomorphine Abandoned AU5204800A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN99108194 1999-06-21
CN99108194 1999-06-21
PCT/CN2000/000145 WO2000078760A1 (en) 1999-06-21 2000-06-08 Process for preparing sildenafil, and troche which comprises sildenafil and apomorphine

Publications (1)

Publication Number Publication Date
AU5204800A true AU5204800A (en) 2001-01-09

Family

ID=5273193

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52048/00A Abandoned AU5204800A (en) 1999-06-21 2000-06-08 Process for preparing sildenafil, and troche which comprises sildenafil and apomorphine

Country Status (2)

Country Link
AU (1) AU5204800A (en)
WO (1) WO2000078760A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102250039A (en) * 2011-05-16 2011-11-23 浙江大学 Ionic liquid of N-methyl piperazine salt and preparation method thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9301192D0 (en) * 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
GB9612514D0 (en) * 1996-06-14 1996-08-14 Pfizer Ltd Novel process
ZA9810766B (en) * 1997-11-28 1999-05-25 Mochida Pharm Co Ltd Novel compounds having cgmp-pde inhibitory activity
CA2235642C (en) * 1998-05-15 2007-11-13 Torcan Chemical Ltd. Processes for preparing sildenafil
IT1301759B1 (en) * 1998-06-19 2000-07-07 Nicox Sa NITRATED SALTS OF ANTI-HYPERTENSIVE DRUGS
GB9822238D0 (en) * 1998-10-12 1998-12-09 Pfizer Ltd Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof

Also Published As

Publication number Publication date
WO2000078760A1 (en) 2000-12-28

Similar Documents

Publication Publication Date Title
AU7825600A (en) Process for producing ethylene
AU2856499A (en) Novel substances kf-1040t4a, kf-1040t4b, kf-1040t5a and kf-1040t5b and process for producing the same
AU1919900A (en) Process for preparing trifluoroarylaluminum etherates
AU3994299A (en) Process for preparing 4-aminodiphenylamines
AU2001292320A1 (en) Benzylamine compound, process for producing the same, and intermediate therefor
AU7060100A (en) Hydrogenation process
AU1538901A (en) Polymersation process
AU6051900A (en) Product substitution search method
AU1149401A (en) Process for preparing jam
AU5214300A (en) Method for producing 2,2,4,4-tetra-substituted 1,3,5-cyclohexanetriones
AU2001280244A1 (en) Novel process for preparing 3-aminomethyl-4-z-methoxyiminopyrrolidine
AU5204800A (en) Process for preparing sildenafil, and troche which comprises sildenafil and apomorphine
AU5123300A (en) Process for preparing 10,11-methanobenzosuberane derivatives
AU2002303824A1 (en) Process for preparing 3-hydroxypropanal
AU1141501A (en) Method for producing hydroxymethylpyridines
AU1283001A (en) Method for producing alkylhalogenosilanes
AU5550700A (en) Novel process
AU1165801A (en) Novel process
AU6169100A (en) Novel process
AUPP888299A0 (en) Improved eduction process
AU5521800A (en) Novel process
AU5995900A (en) Novel process
AU2001234795A1 (en) Process for obtaining 1, 2, 3, 5, 6, 7, 8, 8a-oltahydro-1, 2, 8, 8tetramethylnaphthalen-2-yl!etan-1-one
AU7418100A (en) Method for producing (r) or (s)-hydroxy-gamma-butyrolactone
AU7418600A (en) Fermentation process

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase